EcoR1 Capital as of Sept. 30, 2017
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 39 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Assembly Biosciences | 13.7 | $103M | 2.9M | 34.92 | |
| Fibrogen | 12.4 | $93M | 1.7M | 53.80 | |
| Ironwood Pharmaceuticals (IRWD) | 11.5 | $86M | 5.5M | 15.77 | |
| Ascendis Pharma A S (ASND) | 10.2 | $76M | 2.1M | 36.25 | |
| Kura Oncology (KURA) | 7.5 | $56M | 3.8M | 14.95 | |
| Immunomedics | 5.3 | $40M | 2.9M | 13.98 | |
| Myokardia | 3.9 | $30M | 690k | 42.85 | |
| Galapagos Nv- (GLPG) | 3.3 | $25M | 241k | 101.75 | |
| Marinus Pharmaceuticals | 2.8 | $21M | 3.6M | 5.87 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 2.6 | $20M | 3.9M | 5.05 | |
| Tocagen | 2.5 | $19M | 1.5M | 12.46 | |
| Array BioPharma | 2.0 | $15M | 1.3M | 12.30 | |
| Cytomx Therapeutics (CTMX) | 2.0 | $15M | 830k | 18.17 | |
| Corvus Pharmaceuticals (CRVS) | 1.9 | $15M | 909k | 15.94 | |
| Intec Pharma | 1.8 | $13M | 1.5M | 8.95 | |
| Insmed (INSM) | 1.7 | $13M | 405k | 31.21 | |
| Wave Life Sciences (WVE) | 1.6 | $12M | 564k | 21.75 | |
| Cascadian Therapeutics | 1.6 | $12M | 3.0M | 4.09 | |
| Vertex Pharmaceuticals Inc option | 1.4 | $10M | 68k | 152.04 | |
| Omeros Corporation (OMER) | 1.3 | $9.7M | 450k | 21.62 | |
| Ironwood Pharmaceuticals Inc cl a | 1.3 | $9.8M | 620k | 15.77 | |
| Fate Therapeutics (FATE) | 1.2 | $9.0M | 2.3M | 3.96 | |
| Regulus Therapeutics | 0.9 | $6.5M | 5.2M | 1.25 | |
| Dicerna Pharmaceuticals | 0.7 | $5.5M | 958k | 5.75 | |
| Ovascience | 0.7 | $5.0M | 3.5M | 1.42 | |
| Kindred Biosciences | 0.6 | $4.3M | 545k | 7.85 | |
| Zai Lab (ZLAB) | 0.6 | $4.3M | 160k | 27.00 | |
| Sangamo Biosciences (SGMO) | 0.4 | $3.3M | 222k | 15.00 | |
| Clementia | 0.4 | $3.3M | 194k | 16.89 | |
| Adverum Biotechnologies | 0.4 | $2.8M | 763k | 3.65 | |
| Clovis Oncology | 0.3 | $2.1M | 26k | 82.40 | |
| Xencor (XNCR) | 0.3 | $2.1M | 90k | 22.92 | |
| Seattle Genetics | 0.2 | $1.6M | 30k | 54.40 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $1.5M | 60k | 25.82 | |
| Syros Pharmaceuticals | 0.2 | $1.5M | 104k | 14.72 | |
| Bristol Myers Squibb (BMY) | 0.1 | $1.1M | 17k | 63.72 | |
| Beigene (ONC) | 0.1 | $1.0M | 9.8k | 102.96 | |
| Deciphera Pharmaceuticals | 0.1 | $855k | 45k | 19.00 | |
| Spring Bk Pharmaceuticals In | 0.0 | $269k | 16k | 16.81 |
